Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
GeoVax Labs, Inc. is a biotechnology company developing vaccines and immunotherapies for infectious diseases and cancers. Its portfolio includes COVID-19 vaccines, oncolytic cancer therapies, and vaccines for Mpox, smallpox, Ebola, Zika, malaria, and hemorrhagic fevers. Utilizing proprietary MVA virus-like particle platforms, GeoVax focuses on safe, durable, and broad immune responses for global health and biodefense markets.
This description was generated via AI from an annual report. Updated about 1 year ago.